These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 326440)

  • 1. Enzyme immunoassays with the miniature centrifugal fast analyzer.
    Lasky FD; Ahuja KK; Karmen A
    Clin Chem; 1977 Aug; 23(8):1444-8. PubMed ID: 326440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of "EMIT" technique for serum phenobarbital and diphenylhydantoin assays to the miniature centrifugal analyzer.
    Brunk SD; Hadjiioannou TP; Hadjiioannou SI; Malmstadt HV
    Clin Chem; 1976 Jun; 22(6):905-7. PubMed ID: 1277482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsants in serum, determined with a fully mechanized enzyme analyzer.
    McClean SW; Young DS; Yonekawa W
    Clin Chem; 1977 Jan; 23(1):116-8. PubMed ID: 318935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated homogeneous liposome immunoassay systems for anticonvulsant drugs.
    Kubotsu K; Goto S; Fujita M; Tuchiya H; Kida M; Takano S; Matsuura S; Sakurabayashi I
    Clin Chem; 1992 Jun; 38(6):808-12. PubMed ID: 1597006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand displacement immunoassay--demonstration of its use for the measurement of serum phenobarbital and phenytoin.
    Hinds JA; Pincombe CF; Smith S; Duffy P
    Clin Chim Acta; 1985 Jul; 149(2-3):105-15. PubMed ID: 3928203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme immunoassay of phenytoin and phenobarbital with the centrifugal analyzer.
    London M; Sanabria D; Yau D
    Clin Chem; 1977 Jul; 23(7):1362. PubMed ID: 326438
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of phenobarbital and phenytoin in serum by a mechanized enzyme immunoassay (EMIT) in comparison with a gas-liquid chromatographic method.
    Oellerich M; Külpmann WR; Haeckel R; Heyer R
    J Clin Chem Clin Biochem; 1977 Jun; 15(6):353-8. PubMed ID: 330795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid centrifugal analyzer enzyme immunoassays for phenytoin, phenobarbital, and primidone.
    Lacher DA; Sinn JA; Wills MR; Savory J
    Am J Clin Pathol; 1980 Aug; 74(2):205-8. PubMed ID: 6996473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effective assays for use in monitoring carbamazepine, phenobarbital, and phenytoin in serum.
    Moore FM; Simpson D
    Clin Chem; 1989 Aug; 35(8):1782-4. PubMed ID: 2503270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an automated system (Optimate) for substrate-labeled fluorescent immunoassays.
    Sheehan M; Caron G
    Ther Drug Monit; 1985; 7(1):108-14. PubMed ID: 3887666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automation of the homogeneous substrate-labeled fluorescent immunoassay for theophylline in serum: application to the determination of phenytoin and phenobarbital in serum.
    Fingerhut B; Costanzo R; Chaudri Z; Rizvi S
    Ther Drug Monit; 1982; 4(4):419-25. PubMed ID: 6760476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of phenytoin and phenobarbital in serum or plasma by substrate-labeled fluorescent immunoassay.
    Dean KJ; Thompson SG; Burd JF; Buckler RT
    Clin Chem; 1983 Jun; 29(6):1051-6. PubMed ID: 6303626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of diphenylhydantoin and phenobarbital by enzyme immunoassay and gas-liquid chromatography.
    Schmidt D
    J Neurol; 1976 Jul; 213(1):41-6. PubMed ID: 59797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved approach to sequential addition immunoassay.
    Lasky FD; Al Razi J; Karmen A
    Clin Chem; 1978 Aug; 24(8):1381-5. PubMed ID: 354821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new immunoassay for determination of phenytoin and phenobarbital: results of a European collaborative control study.
    Schmidt D; Goldberg V; Guelen PJ; Johannessen S; Kleijn E; Meijer JW; Meinardi H; Richens A; Schneider H; Stein-Lavie Y; Symann-Louette N
    Epilepsia; 1977 Sep; 18(3):367-74. PubMed ID: 891490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence polarization immunoassay IV. Determination of phenytoin and phenobarbital in human serum and plasma.
    Lu-Steffes M; Pittluck GW; Jolley ME; Panas HN; Olive DL; Wang CH; Nystrom DD; Keegan CL; Davis TP; Stroupe SD
    Clin Chem; 1982 Nov; 28(11):2278-82. PubMed ID: 6751601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hyperlipidemia on therapeutic drug assays.
    Baer DM; Paulson RA
    Ther Drug Monit; 1987; 9(1):72-7. PubMed ID: 3554630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of phenobarbital and phenytoin by dry-phase apoenzyme reactivation immunoassay system (ARIS).
    Croci D; Nespolo A; Tarenghi G
    Ther Drug Monit; 1987 Jun; 9(2):197-202. PubMed ID: 3303469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nephelometric inhibition immunoassay (NIIA), a new methodology for the determination of phenobarbital and phenytoin concentration in serum (author's transl)].
    Liappis N
    Klin Padiatr; 1982 Mar; 194(2):88-90. PubMed ID: 7047885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the cloned enzyme donor immunoassay for measurement of phenytoin and phenobarbital in serum.
    van der Weide J; Luiting HJ; Veefkind AH
    Ther Drug Monit; 1993 Aug; 15(4):344-8. PubMed ID: 8236372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.